Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease.
Davies
Mark G
MG
Center for Vascular Disease, Division of Vascular Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA. mark_davies@urmc.rochester.edu
Waldman
David L
DL
Pearson
Thomas A
TA
D000800:Angioplasty, Balloon / Q000379:methods*; D001157:Arterial Occlusive Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D001161:Arteriosclerosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D003131:Combined Modality Therapy; D005081:Exercise Therapy; D005263:Femoral Artery; D015316:Genetic Therapy; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008019:Life Style; D016491:Peripheral Vascular Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D011150:Popliteal Artery; D012307:Risk Factors; D040242:Risk Reduction Behavior; D012907:Smoking / Q000009:adverse effects; D000074606:Smoking Prevention; D015607:Stents; D016896:Treatment Outcome; D014654:Vascular Patency
D000960:Hypolipidemic Agents